Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli Ulcer.
Buruli ulcer (BU) is the third most frequent mycobacterial disease in immunocompetent persons after tuberculosis and leprosy. During the last decade, eight weeks of antimicrobial treatment has become the standard of care. This treatment may be accompanied by transient clinical deterioration, known a...
Saved in:
Main Authors: | Yves Thierry Barogui (Author), Sandor-Adrian Klis (Author), Roch Christian Johnson (Author), Richard O Phillips (Author), Eveline van der Veer (Author), Cleo van Diemen (Author), Tjip S van der Werf (Author), Ymkje Stienstra (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2016-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial.
by: Sandor Klis, et al.
Published: (2014) -
Towards rational use of antibiotics for suspected secondary infections in Buruli ulcer patients.
by: Yves T Barogui, et al.
Published: (2013) -
Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management.
by: Anita Velink, et al.
Published: (2016) -
Good quality of life in former Buruli ulcer patients with small lesions: long-term follow-up of the BURULICO trial.
by: Sandor Klis, et al.
Published: (2014) -
Assessment and Treatment of Pain during Treatment of Buruli Ulcer.
by: Janine de Zeeuw, et al.
Published: (2015)